Roles for VEGF in the adult

被引：159

作者：

Maharaj, Arindel S. R.

D'Amore, Patricia A.

机构：

[1] Schepens Eye Res Inst, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02114 USA

[3] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA

[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA

来源：

MICROVASCULAR RESEARCH | 2007年 / 74卷 / 2-3期

关键词：

VEGF; angiogenesis; preeclampsia; anti-angiogenic therapy; bevacizumab; endothelial cells; avastin; fenestrations;

D O I：

10.1016/j.mvr.2007.03.004

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease precclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies. Published by Elsevier Inc.

引用

收藏

页码：100 / 113

页数：14

相关论文

共 188 条

[1] Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and-2 suggests an important role of astrocytes in cerebellar vascularization [J].

Acker, T ;

Beck, H ;

Plate, KH .

MECHANISMS OF DEVELOPMENT, 2001, 108 (1-2) :45-57

[2] Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer [J].

Allen, Jeffrey A. ;

Adlakha, Ashish ;

Bergethon, Peter R. .

ARCHIVES OF NEUROLOGY, 2006, 63 (10) :1475-1478

[3] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].

ALON, T ;

HEMO, I ;

ITIN, A ;

PEER, J ;

STONE, J ;

KESHET, E .

NATURE MEDICINE, 1995, 1 (10) :1024-1028

[4] Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier [J].

Ambati, Balamurali K. ;

Patterson, Emory ;

Jani, Pooja ;

Jenkins, Crystal ;

Higgins, Eric ;

Singh, Nirbhai ;

Suthar, Tushar ;

Vira, Nehali ;

Smith, Kimberly ;

Caldwell, Ruth .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (04) :505-508

[5] Corneal avascularity is due to soluble VEGF receptor-1 [J].

Ambati, Balamurali K. ;

Nozaki, Miho ;

Singh, Nirbhai ;

Takeda, Atsunobu ;

Jani, Pooja D. ;

Suthar, Tushar ;

Albuquerque, Romulo J. C. ;

Richter, Elizabeth ;

Sakurai, Eiji ;

Newcomb, Michael T. ;

Kleinman, Mark E. ;

Caldwell, Ruth B. ;

Lin, Qing ;

Ogura, Yuichiro ;

Orecchia, Angela ;

Samuelson, Don A. ;

Agnew, Dalen W. ;

St. Leger, Judy ;

Green, W. Richard ;

Mahasreshti, Parameshwar J. ;

Curiel, David T. ;

Kwan, Donna ;

Marsh, Helene ;

Ikeda, Sakae ;

Leiper, Lucy J. ;

Collinson, J. Martin ;

Bogdanovich, Sasha ;

Khurana, Tejvir S. ;

Shibuya, Masabumi ;

Baldwin, Megan E. ;

Ferrara, Napoleone ;

Gerber, Hans-Peter ;

De Falco, Sandro ;

Witta, Jassir ;

Baffi, Judit Z. ;

Raisler, Brian J. ;

Ambati, Jayakrishna .

NATURE, 2006, 443 (7114) :993-997

[6] Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells -: Comparison of the effects of heparin and modified heparins [J].

Ashikari- Hada, S ;

Habuchi, H ;

Kariya, Y ;

Kimata, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (36) :31508-31515

[7] VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model [J].

Azzouz, M ;

Ralph, GS ;

Storkebaum, E ;

Walmsley, LE ;

Mitrophanous, KA ;

Kingsman, SM ;

Carmeliet, P ;

Mazarakis, ND .

NATURE, 2004, 429 (6990) :413-417

[8] Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules [J].

Baffert, F ;

Le, T ;

Thurston, G ;

McDonald, DM .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (01) :H107-H118

[9] Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling [J].

Baffert, F ;

Le, T ;

Sennino, B ;

Thurston, G ;

Kuo, CJ ;

Hu-Lowe, D ;

McDonald, DM .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (02) :H547-H559

[10] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 [J].

Barleon, B ;

Sozzani, S ;

Zhou, D ;

Weich, HA ;

Mantovani, A ;

Marme, D .

BLOOD, 1996, 87 (08) :3336-3343

← 1 2 3 4 5 6 7 8 9 10 →